[1] |
WANG Jie, LI Long, CHEN Feng, LIU Shengfei.
Research progress of nuclear factor erythroid 2-related factor 2 in pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1067-1072.
|
[2] |
WANG Yan, ZHANG Jinhui, ZHAO Yongchen, LIU Hongxiang, LIU Yawei, MIAO Huanhuan, YANG Xincai.
Sequoiaflavone inhibits stem cell properties such as proliferation and invasion of gastric cancer cells by down-regulating PI3K/AKT signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 508-513.
|
[3] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[4] |
SUI Yuxia, ZHUANG Jie, ZHUANG Min, HUANG Gui.
Delicaflavone inhibits the invasion and migration of gefitinib-resistant lung cancer PC-9/GR cells by regulating epithelial-mesenchymal transition via PI3K/Akt/mTOR pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 614-621.
|
[5] |
SHI Jingbin, XIONG Yang.
Research progress on interaction between tumor microenvironment and breast cancer cells leading to tumor metastasis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 562-574.
|
[6] |
YE Xiaodi, MIAO Yunping, CHEN Aiying, CHENG Min, TIAN Xuejun, ZHENG Gaoli .
Optimization and verification of orthotopic non-muscle invasive bladder cancer model in nude mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 473-480.
|
[7] |
LI Yanyan, FANG Xiaojie, YIN Xin, SUN Xi, RAO Chunhui.
circZNF124 regulates the proliferation, migration and invasion of colorectal cancer SW620 cells by targeting miR-4262
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1231-1239.
|
[8] |
ZHOU Shiqin, LUO Yali, ZHOU Wen, Qi Xiaofeng, XIAO Mengyong.
Molecular mechanism and treatment of pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1133-1147.
|
[9] |
LIU Le, QI Wenbo, BAI Yuping, LIU Qian, YIN Zhenyu, LI Xiaomei, YU Yang, CHEN Hao.
Influencing factors of PD-1/PD-L1 immune checkpoint inhibitor immunotherapy for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 95-101.
|
[10] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[11] |
Pazilaiti YASEN, YUAN Hao, LU Hong, ZHENG Ya, WANG Yuping, ZHOU Yongning.
Research progress in clinical trials of targeted drugs for gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 454-461.
|
[12] |
CHEN Linjun, CHEN Wenbin.
Jolkinolide B inhibits the proliferation and metastasis of colon cancer cells via blocking PI3K/Akt/NF-κB pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 250-257.
|
[13] |
WU Yi, ZHU Akao, SHAN Yuqiang, YING Rongchao, JIN Huicheng.
Resveratrol regulates miR-409-3p/FKBP14 to inhibit the malignant biological processes of gastric cancer BGC823 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 968-975.
|
[14] |
HOU Bin, HUANG Weiping, YIN Zhongpu, HU Shousen.
lncRNA PCAT19 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells by adsorbing miR-142-5p and regulating the expression of ING3 gene
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 721-727.
|
[15] |
TIAN Dahao, LU Linming, ZHI Hui, ZHOU Jue, WANG Xiaoqing, JIANG Yuhua.
AHVAC-I inhibits the proliferation in human primary gastric cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(5): 505-511.
|